Pemphigoid Gestationis - literature review
DOI:
https://doi.org/10.12775/JEHS.2024.70.55567Keywords
pemphigoid gestationis, skin lesions, dermatoses of pregnancyAbstract
Introduction and Objective: Pemphigoid gestationis (PG) is a rare, self-limiting autoimmune disorder, typically appearing in the second or third trimester of pregnancy. It can lead to postpartum exacerbations, and studies suggest an increased risk of preterm birth and the development of Graves' disease in the mother. The aim of this article is to gather the latest information on pemphigoid gestationis.
Review Methods: A review of studies available in the PubMed database was conducted using the keywords "pemphigoid gestationis" and "dermatoses of pregnancy" in order to find publications from the last 8 years.
Brief Description of the State of Knowledge: Pemphigoid gestationis (PG) is characterized by the production of IgG1 antibodies against bullous pemphigoid antigen 180 (BP180). The primary symptom of PG is intense itching, which often occurs before skin lesions develop. Diagnosis is typically confirmed through direct immunofluorescence (DIF) of perilesional skin. Treatment focuses on relieving itching and preventing new blister formation, usually starting with topical corticosteroids for mild cases, while systemic corticosteroids are reserved for more severe presentations. Recent research indicates that biologic therapies may also offer effective management options for PG.
Summary: The authors highlight the need for further research due to the limited sample sizes in existing studies, as well as the potential complications during pregnancy and long-term health effects.
References
Fong M, Gandhi GR, Gharbi A, et al. Pemphigoid Gestationis.Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
https://www.ncbi.nlm.nih.gov/books/NBK470287/ (access 2024.10.08)
Sävervall C, Sand FL, Thomsen SF. Pemphigoid gestationis: current perspectives. Clin Cosmet Investig Dermatol. 2017 Nov 8;10:441-449. https://doi.org/10.2147/CCID.S128144
Ceryn J, Siekierko A, Skibińska M, Doss N, Narbutt J, Lesiak A. Pemphigoid Gestationis - Case Report and Review of Literature. Clin Cosmet Investig Dermatol. 2021 Jun 16;14:665-670 https://doi.org/10.2147/CCID.S297520
Hallaji Z, Mortazavi H, Ashtari S, Nikoo A, Abdollahi M, Nasimi M. Pemphigoid gestationis: Clinical and histologic features of twenty-three patients. Int J Womens Dermatol. 2016 Dec 23;3(2):86-90. https://doi.org/10.1016/j.ijwd.2016.11.004
Stefaniak AA, Pereira MP, Zeidler C, Ständer S. Pruritus in Pregnancy. Am J Clin Dermatol. 2022 Mar;23(2):231-246. https://doi.org/10.1007/s40257-021-00668-7
Al-Saif F, Elisa A, Al-Homidy A, Al-Ageel A, Al-Mubarak M. Retrospective analysis of pemphigoid gestationis in 32 Saudi patients - Clinicopathological features and a literature review. J Reprod Immunol. 2016 Aug;116:42-5. https://doi.org/10.1016/j.jri.2016.04.286
Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999 Jul;24(4):255-9. https://doi.org/10.1046/j.1365-2230.1999.00472.x
Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999 Jul;141(1):71-81. https://doi.org/10.1046/j.1365-2133.1999.02923.x
Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006 Mar;54(3):395-404. https://doi.org/10.1016/j.jaad.2005.12.012
Montagnon CM, Tolkachjov SN, Murrell DF, Camilleri MJ, Lehman JS. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis. J Am Acad Dermatol. 2021 Jul;85(1):1-14. https://doi.org/10.1016/j.jaad.2020.11.076
Patel F, Wilken R, Patel FB, Sultani H, Bustos I, Duong C, Zone JJ, Raychaudhuri SP, Maverakis E. Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture. Indian J Dermatol. 2017 May-Jun;62(3):262-267. https://doi.org/10.4103/0019-5154.159620
Daniel BS, Murrell DF. Review of autoimmune blistering diseases: the Pemphigoid diseases. J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1685-1694. https://doi.org/10.1111/jdv.15679
Kukkamalla RM, Bayless P. Pemphigoid Gestationis. Clin Pract Cases Emerg Med. 2019 Jan 7;3(1):79-80. https://doi.org/10.5811/cpcem.2018.11.39258
Lobato-Berezo A, Fernández Figueras MT, Moreno Romero JA, Pujol RM. Pemphigoid Gestationis Mimicking Erythema Multiforme With Mucosal Involvement. Actas Dermosifiliogr (Engl Ed). 2019 Oct;110(8):696-697. https://doi.org/10.1016/j.ad.2018.02.038
Maglie R, Quintarelli L, Verdelli A, Fabbri P, Antiga E, Caproni M. Specific dermatoses of pregnancy other than pemphigoid gestationis. G Ital Dermatol Venereol. 2019 Jun;154(3):286-298. https://doi.org/10.23736/S0392-0488.18.06159-X
Almeida FT, Sarabando R, Pardal J, Brito C. Pemphigoid gestationis successfully treated with intravenous immunoglobulin. BMJ Case Rep. 2018 Apr 7;2018:bcr2018224346. https://doi.org/10.1136/bcr-2018-224346
Lipozenčić J, Ljubojevic S, Bukvić-Mokos Z. Pemphigoid gestationis. Clin Dermatol. 2012 Jan-Feb;30(1):51-55. https://doi.org/10.1016/j.clindermatol.2011.03.009
Semkova K, Black M. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol. 2009 Aug;145(2):138-44. https://doi.org/10.1016/j.ejogrb.2009.05.012
Feliciani C, Genovese G, D'astolto R, Pontini P, Marzano AV. Autoimmune bullous diseases during pregnancy: insight into pathogenetic mechanisms and clinical features. G Ital Dermatol Venereol. 2019 Jun;154(3):256-262. https://doi.org/10.23736/S0392-0488.18.06153-9
Papapanagiotou IK, Tsagouri S, Liakou CG, Besharat A, Vogiatzis N, Ntzeros K, Petrakis E, Koutroumanis P, Thomakos N, Loutradis D. Pemphigoid gestationis. Clin Case Rep. 2018 May 7;6(7):1364-1365. https://doi.org/10.1002/ccr3.1545
Bechtel MA. Pruritus in Pregnancy and Its Management. Dermatol Clin. 2018 Jul;36(3):259-265. https://doi.org/10.1016/j.det.2018.02.012
Yang A, Uhlenhake E, Murrell DF. Pemphigoid gestationis and intravenous immunoglobulin therapy. Int J Womens Dermatol. 2018 May 3;4(3):166-169. https://doi.org/10.1016/j.ijwd.2018.03.007
Al-Shenawy HA. Can immunohistochemistry replace immunofluorescence in diagnosis of skin bullous diseases? APMIS. 2017 Feb;125(2):114-121. https://doi.org/10.1111/apm.12643
Schauer F, Mai S, Hofmann SC, Mai Y, Izumi K, Kern JS, Kiritsi D. Autoreactivity to BP180 Neoepitopes in Patients With Pemphigoid Gestationis. JAMA Dermatol. 2022 Feb 1;158(2):212-214. https://doi.org/10.1001/jamadermatol.2021.5294
Genovese G, Derlino F, Cerri A, Moltrasio C, Muratori S, Berti E, Marzano AV. A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis. Front Med (Lausanne). 2020 Nov 20;7:604945. https://doi.org/10.3389/fmed.2020.604945
Patsatsi A, Marinovic B, Murrell D. Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues. Int J Womens Dermatol. 2019 Jan 24;5(3):166-170. https://doi.org/10.1016/j.ijwd.2019.01.003
Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol. 2018 May;59(2):86-100. https://doi.org/10.1111/ajd.12641
Kushner CJ, Concha JSS, Werth VP. Treatment of Autoimmune Bullous Disorders in Pregnancy. Am J Clin Dermatol. 2018 Jun;19(3):391-403. https://doi.org/10.1007/s40257-018-0342-0
Patel PM, Jones VA, Murray TN, Amber KT. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020 Aug;21(4):557-565. https://doi.org/10.1007/s40257-020-00513-3
Killion L, Beatty P, Tierney E, Hackett C, Tobin AM, O'Brennan E. Severe pemphigoid gestationis responsive to intravenous immunoglobulins after initial treatment failure of combined oral steroids and cyclosporin. Eur J Dermatol. 2021 Apr 1;31(2):245-246. https://doi.org/10.1684/ejd.2021.4006
Tourte M, Brunet-Possenti F, Mignot S, Gavard L, Descamps V. Pemphigoid gestationis: a successful preventive treatment by rituximab. J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e206-e207. https://doi.org/10.1111/jdv.13962
Sood S, Yeung J, Mufti A. Biologic therapy for refractory pemphigoid gestationis: An evidence-based systematic review. JAAD Int. 2023 Aug 31;13:134-136. https://doi.org/10.1016/j.jdin.2023.08.015
Chen RE, Yokoyama CC, Anadkat MJ. Pemphigoid gestationis treated with dupilumab. JAAD Case Rep. 2023 Sep 7;41:10-12. https://doi.org/10.1016/j.jdcr.2023.08.013
Jiao HN, Ruan YP, Liu Y, Pan M, Zhong HP. Diagnosis, fetal risk and treatment of pemphigoid gestationis in pregnancy: A case report. World J Clin Cases. 2021 Dec 6;9(34):10645-10651. https://doi.org/10.12998/wjcc.v9.i34.10645
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Krystian Wdowiak, Agnieszka Maciocha, Julia Wąż, Aleksandra Witas, Justyna Drogoń, Weronika Chachaj, Paulina Słomka, Edyta Gwóźdź, Natalia Szymkowiak, Ewa Gardocka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 45
Number of citations: 0
